Related Experiment Video
Updated: Feb 21, 2026

12:34
Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction
Published on: January 3, 2020
17.4K
Robotic Retrocaval Metastasectomy After an Ipsilateral Radical Nephrectomy
Ryan J Nelson1, Jeremy H Reese1, Paurush Babbar1
1Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.
Urology
|October 7, 2017
Summary
Robotic surgery successfully removed a large retrocaval metastasis from recurrent chromophobe renal cell carcinoma (RCC). This minimally invasive approach offers excellent visualization for complex cases, with the patient remaining cancer-free.
Area of Science:
- Urology
- Surgical Oncology
- Robotic Surgery
Background:
- Managing retrocaval masses after prior surgery presents challenges due to scarring and obscured surgical planes.
- Recurrence of renal cell carcinoma (RCC) as a retrocaval metastasis requires careful surgical planning.
- Previous laparoscopic right radical nephrectomy and adrenalectomy complicated the dissection of the retrocaval area.
Observation:
- A 62-year-old male with a history of chromophobe RCC presented with a 5-cm retrocaval mass confirmed by biopsy.
- The mass was adherent to the inferior vena cava (IVC) and duodenum, necessitating meticulous dissection.
- Robotic positioning facilitated precise manipulation and visualization of the retrocaval space.
Findings:
- Robotic retrocaval metastasectomy was performed with an operative time of 234 minutes and estimated blood loss of 40 cc.
- The excised 5 cm mass was a metastatic chromophobe RCC with negative surgical margins.
- Histopathology confirmed metastatic RCC, chromophobe-type, involving a lymph node.
Implications:
- Robotic surgery provides enhanced visualization and access for complex retrocaval dissections, offering a minimally invasive option.
- Successful robotic metastasectomy for recurrent RCC demonstrates the feasibility of this approach in challenging anatomical locations.
- A high level of robotic surgical expertise is crucial for managing adhered retrocaval masses, ensuring patient safety and oncological outcomes.

